165 filings
Page 7 of 9
8-K
8d8dix3u5koc62h7k7m
26 Mar 19
PhaseBio Reports Fourth Quarter and Full-Year 2018 Financial and Business Results
4:05pm
8-K
i9t3mychf1o
21 Mar 19
PB2452 achieved immediate and sustained reversal of ticagrelor antiplatelet effects
4:05pm
8-K
u9zqe31z5 ei9zbgda
4 Mar 19
PhaseBio Appoints Richard A. van den Broek to Board of Directors
8:00am
8-K
zdt kuzihw
25 Jan 19
Material Modifications to Rights of Security Holders
4:05pm
8-K
o86x 6oi99kj
17 Dec 18
PhaseBio Appoints Edmund P. Harrigan to Board of Directors
4:36pm
10-Q
d89nd
29 Nov 18
Quarterly report
4:53pm
8-K
qqll tl142h
29 Nov 18
PhaseBio Reports Third Quarter 2018 Financial and Business Results
4:41pm
S-8
aadh1s0hzfl vw
22 Oct 18
Registration of securities for employees
5:18pm
8-K
xqhuu
22 Oct 18
Amendments to Articles of Incorporation or Bylaws
4:34pm
424B4
ji517lxucq4s1y5y0
19 Oct 18
Prospectus supplement with pricing info
12:00am
CT ORDER
ue9y2u0h03lpvydp
18 Oct 18
Confidential treatment order
10:16am
EFFECT
k7txamt ne
18 Oct 18
Notice of effectiveness
12:15am
POS EX
snjptziakw wufo
17 Oct 18
Additional exhibits for listing
9:31pm
FWP
gnal6m rx
17 Oct 18
Free writing prospectus
8:39pm
CERT
uu32eer0 gmawvu4fhd
15 Oct 18
Certification of approval for exchange listing
10:35am
CORRESP
6putkikchixqla 4zqpx
15 Oct 18
Correspondence with SEC
12:00am
CORRESP
xj0t3m9wd
15 Oct 18
Correspondence with SEC
12:00am
8-A12B
kqronrcbcry7rzh9j8
9 Oct 18
Registration of securities on exchange
3:16pm
S-1/A
apr5xg 12ag
5 Oct 18
IPO registration (amended)
5:11pm